Rhode Island S2888 allows pharmacists to prescribe FDA-approved tobacco cessation therapies, with required education and coverage by health insurers.

Rhode Island S2888 establishes conditions for pharmacists to prescribe tobacco cessation drug therapies. It mandates that pharmacists complete education approved by the state board of pharmacy before prescribing. The bill requires health insurance carriers to cover these services starting January 1, 2027, within their provider networks and outside them if necessary. It also ensures that pharmacists' services are not subject to supervision, signature, or referral requirements by other healthcare providers.

Rhode Island S2888 allows pharmacists to prescribe FDA-approved tobacco cessation therapies, with required education and coverage by health insurers.

Rhode Island S2888 establishes conditions for pharmacists to prescribe tobacco cessation drug therapies. It mandates that pharmacists complete education approved by the state board of pharmacy before prescribing. The bill requires health insurance carriers to cover these services starting January 1, 2027, within their provider networks and outside them if necessary. It also ensures that pharmacists' services are not subject to supervision, signature, or referral requirements by other healthcare providers.